Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

June 23, 2015

Primary Completion Date

October 13, 2017

Study Completion Date

February 2, 2018

Conditions
Asthma
Interventions
DRUG

placebo

Matching placebo for risankizumab

DRUG

risankizumab

Monoclonal IgG antibody

Trial Locations (65)

1070

ULB Hopital Erasme, Brussels

1200

Brussels - UNIV St-Luc, Brussels

3000

UZ Leuven, Leuven

4000

Centre Hospitalier Universitaire de Liège, Liège

10717

Praxis Dr. Linnhoff, Berlin, Berlin

12203

MECS Research GmbH, Berlin, Berlin

13915

HOP Nord, Marseille

14215

VA WNY Healthcare System, Buffalo

15213

University of Pittsburgh Medical Center, Pittsburgh

15243

Research Protocol Mgmt Spc, Pittsburgh

15562

IFG Institut für Gesundheitsförderung GmbH, Rüdersdorf

19140

Temple University School of Medicine, Philadelphia

20354

Hamburger Institut für Therapieforschung GmbH (HIT), Hamburg

20401

Chang Gung Memorial Hospital Keelung, Keelung

21224

Johns Hopkins Hospital, Baltimore

22030

O and O Alpan, LLC, Fairfax

23552

KLB Gesundheitsforschung Lübeck GmbH, Lübeck

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel

27104

Wake Forest School of Medicine, Winston-Salem

28207

American Health Research, Inc., Charlotte

28562

Coastal Carolina Health Care, P.A., New Bern

29204

MedTrial, LLC, Columbia

29615

VitaLink Research, Greenville

30033

Specjalistyczny Osrodek Alergologiczno-Intern. ALL-MED, Krakow

30173

Praxis Dr. Hoffmann, Hannover, Hanover

31066

Univ. Hospital in Krakow,Pulmonology Clinical Dept, Krakow

33607

Clinical Research Trials of Florida, Inc., Tampa

34295

HOP Arnaud de Villeneuve, Montpellier

38043

HOP CHU de Grenoble, Grenoble

40447

China Medical University Hospital, Taichung

44093

HOP Nord Laënnec, Nantes

44789

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH, Bochum

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

56068

KPPK GmbH, Studienzentrum, Koblenz

60389

Praxis Dr. med. Claus Keller, Frankfurt

60596

IKF Pneumologie GmbH & Co. KG, Frankfurt

Medaimun GmbH, Frankfurt

60611

Northwestern University, Chicago

63110

Washington University School of Medicine, St Louis

63263

Institut für klinische Forschung GmbH, Neu-Isenburg

66421

Universitätsklinikum des Saarlandes, Homburg/Saar

75018

HOP Bichat, Paris

77380

Respiratory and Sleep Disorders Specialists, The Woodlands

80112

IMMUNOe Research Centers, Centennial

90141

Barlicki University Hospital No. 1, Lodz

92626

WCCT Global, LLC, Costa Mesa

94040

El Camino Hospital, Mountain View

06504

Yale New Haven Hospital, New Haven

02115

Brigham and Women's Hospital, Boston

V5Z 1M9

Vancouver General Hospital, Vancouver

L7N 3V2

Burlington Lung Clinic, Burlington

L8N 4A6

Airway Inflammometry Laboratory, Hamilton

2333 ZA

Leids Universitair Medisch Centrum (LUMC), Leiden

2545 CH

HagaZiekenhuis, The Hague

40-752

Gibinski Univ.Clin.Cnter of Silesian Med.Uni.Katowice,Outpat, Katowice

90 141

Barlicki University Hospital No. 1, Lodz

361-771

Chungbuk National University Hospital, Cheongju-si

501-757

Chonnam National University Hospital, Gwangju

08308

Korea University Guro Hospital, Seoul

130-709

The Catholic University of Korea, St.Paul's Hospital, Seoul

BT9 6AD

Celerion Inc, Belfast

BD9 6RJ

Bradford Royal Infirmary, Bradford

LE3 9QP

Glenfield Hospital, Leicester

M23 9QZ

The Medicines Evaluation Unit, Manchester

ML2 0DP

Wishaw General Hospital, Wishaw

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

AbbVie

INDUSTRY